Trametinib | CAS 871700-17-3 - Request Quote
Trametinib
| SZ CAT No: | SZ-T121021 |
| CAS No | 871700-17-3 |
| Mol.F. | C26H23FIN5O4 |
| Mol.Wt. | 615.4 |
| Inv. Status | In Stock |
| Rel. CAS No | 871702-07-7 (Acetate salt) ; 871702-06-6 (sodium salt) ; 1187431-31-7 (hydrate) ; 1290629-63-8 (HCl salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Trametinib is chemically N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide. Trametinib is supplied with detailed characterization data compliant with regulatory guideline. Trametinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Trametinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 871700-17-3
Purchase 871700-17-3
Order 871700-17-3
Enquire 871700-17-3
price of 871700-17-3
871700-17-3 Supplier
871700-17-3 Manufacturer
871700-17-3 Exporter
buy high quality Trametinib
Purchase Trametinib
Trametinib suppliers
Trametinib manufacturers
Trametinib price
Order Trametinib
Enquire Trametinib
Trametinib cost
Trametinib Supplier
Trametinib Distributor
Trametinib for Method Validation
Trametinib Reference Standard
Trametinib for ANDA Filing
Trametinib for Forced Degradation Studies
Trametinib Identification Standards
Trametinib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.